The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Doxorubicin, DNA torsion, and chromatin dynamics
Open accessAbstract
Doxorubicin is one of the most important anti-cancer chemotherapeutic drugs, being widely used for the treatment of solid tumors and acute leukemias. The action of doxorubicin and other anthracycline drugs has been intensively investigated during the last several decades, but the mechanisms that have been proposed for cell killing remain disparate and controversial. In this review, we examine the proposed models for doxorubicin action from the perspective of the chromatin landscape, which is altered in many types of cancer due to recurrent mutations in chromatin modifiers. We highlight recent evidence for effects of anthracyclines on DNA torsion and chromatin dynamics that may underlie basic mechanisms of doxorubicin-mediated cell death and suggest new therapeutic strategies for cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Topological domains in mammalian genomes identified by analysis of chromatin interactions
Dixon, J. R., Selvaraj, S., Yue, F., Kim, A., Li, Y., Shen, Y., Hu, M., Liu, J. S., & Ren, B. (2012) · Nature · doi:10.1038/nature11082 · Cited by 6,829
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,778
The Biology of Chromatin Remodeling Complexes
Clapier, C. R., & Cairns, B. R. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.062706.153223 · Cited by 2,380
Gewirtz, D. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00307-4 · Cited by 2,240
Supercoiling of the DNA template during transcription.
Liu, L. F., & Wang, J. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7024 · Cited by 1,962
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L.-S., Lyu, Y. L., Liu, L. F., & Yeh, E. T. H. (2012) · Nature Medicine · doi:10.1038/nm.2919 · Cited by 1,948
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Pommier, Y., Leo, E., Zhang, H., & Marchand, C. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.04.012 · Cited by 1,829
Targeting DNA topoisomerase II in cancer chemotherapy
Nitiss, J. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2607 · Cited by 1,791
Doxorubicin pathways: pharmacodynamics and adverse effects
Thorn, C. F., Oshiro, C., Marsh, S., Hernandez-Boussard, T., McLeod, H., Klein, T. E., & Altman, R. B. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833ffb56 · Cited by 1,648
Transcription generates positively and negatively supercoiled domains in the template
Wu, H.-Y., Shyy, S., Wang, J. C., & Liu, L. F. (1988) · Cell · doi:10.1016/0092-8674(88)90163-8 · Cited by 743
Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesius
Arcamone, F., Cassinelli, G., Fantini, G., Grein, A., Orezzi, P., Pol, C., & Spalla, C. (1969) · Biotechnology and Bioengineering · doi:10.1002/bit.260110607 · Cited by 622
Doxorubicin Induces Apoptosis in Normal and Tumor Cells via Distinctly Different Mechanisms
Wang, S., Konorev, E. A., Kotamraju, S., Joseph, J., Kalivendi, S., & Kalyanaraman, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400944200 · Cited by 611
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
Wu, C.-C., Li, T.-K., Farh, L., Lin, L.-Y., Lin, T.-S., Yu, Y.-J., Yen, T.-J., Chiang, C.-W., & Chan, N.-L. (2011) · Science · doi:10.1126/science.1204117 · Cited by 523
Genome-Wide Kinetics of Nucleosome Turnover Determined by Metabolic Labeling of Histones
Deal, R. B., Henikoff, J. G., & Henikoff, S. (2010) · Science · doi:10.1126/science.1186777 · Cited by 471
Self-citationPang, B., Qiao, X., Janssen, L., Velds, A., Groothuis, T., Kerkhoven, R., Nieuwland, M., Ovaa, H., Rottenberg, S., van Tellingen, O., et al. (2013) · Nature Communications · doi:10.1038/ncomms2921 · Cited by 420
Jackson, J. G., Pant, V., Li, Q., Chang, L. L., Quintás-Cardama, A., Garza, D., Tavana, O., Yang, P., Manshouri, T., Li, Y., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.027 · Cited by 329
Doxorubicin-DNA Adducts Induce a Non-Topoisomerase II–Mediated Form of Cell Death
Swift, L. P., Rephaeli, A., Nudelman, A., Phillips, D. R., & Cutts, S. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3410 · Cited by 314
The combined status of ATM and p53 link tumor development with therapeutic response
Jiang, H., Reinhardt, H. C., Bartkova, J., Tommiska, J., Blomqvist, C., Nevanlinna, H., Bartek, J., Yaffe, M. B., & Hemann, M. T. (2009) · Genes & Development · doi:10.1101/gad.1815309 · Cited by 304
Ceramide glycosylation potentiates cellular multidrug resistance
LIU, Y., HAN, T., GIULIANO, A. E., & CABOT, M. C. (2001) · The FASEB Journal · doi:10.1096/fj.00-0223com · Cited by 303
Topoisomerase levels determine chemotherapy response in vitro and in vivo
Burgess, D. J., Doles, J., Zender, L., Xue, W., Ma, B., McCombie, W. R., Hannon, G. J., Lowe, S. W., & Hemann, M. T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803513105 · Cited by 300
Berlin, V., & Haseltine, W. A. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69315-4 · Cited by 275
Histone Acetylation Regulates Intracellular pH
McBrian, M. A., Behbahan, I. S., Ferrari, R., Su, T., Huang, T.-W., Li, K., Hong, C. S., Christofk, H. R., Vogelauer, M., Seligson, D. B., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.025 · Cited by 272
Generation of Superhelical Torsion by ATP-Dependent Chromatin Remodeling Activities
Havas, K., Flaus, A., Phelan, M., Kingston, R., Wade, P. A., Lilley, D. M. J., & Owen-Hughes, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00215-4 · Cited by 271
Adriamycin (NSC-123,127): a new antibiotic with antitumor activity.
Marco, A. D., Gaetani, M., & Scarpinato, B. (1969) · PubMed · Cited by 243
Chaires, J. B., Herrera, J. E., & Waring, M. J. (1990) · Biochemistry · doi:10.1021/bi00478a006 · Cited by 214
Valproic Acid Alters Chromatin Structure by Regulation of Chromatin Modulation Proteins
Marchion, D. C., Bicaku, E., Daud, A. I., Sullivan, D. M., & Munster, P. N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2478 · Cited by 212
DNA damage is an early event in doxorubicin-induced cardiac myocyte death
L'Ecuyer, T., Sanjeev, S., Thomas, R., Novak, R., Das, L., Campbell, W., & Heide, R. V. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00738.2005 · Cited by 212
Transcription-generated torsional stress destabilizes nucleosomes
Teves, S. S., & Henikoff, S. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2723 · Cited by 210
Self-citationAdriamycin-induced Cardiomyocyte and Endothelial Cell Apoptosis: In Vitro and In Vivo Studies
Wu, S. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2110 · Cited by 197
Targeting Histone Demethylases: A New Avenue for the Fight against Cancer
Rotili, D., & Mai, A. (2011) · Genes & Cancer · doi:10.1177/1947601911417976 · Cited by 191
Structure of the SWI2/SNF2 chromatin-remodeling domain of eukaryotic Rad54
Thomä, N. H., Czyzewski, B. K., Alexeev, A. A., Mazin, A. V., Kowalczykowski, S. C., & Pavletich, N. P. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb919 · Cited by 186
De Beer, E. L., Bottone, A. E., & Voest, E. E. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00765-8 · Cited by 185
Site and sequence specificity of the daunomycin-DNA interaction
Chaires, J. B., Fox, K. R., Herrera, J. E., Britt, M., & Waring, M. J. (1987) · Biochemistry · doi:10.1021/bi00399a031 · Cited by 178
The role of iron in doxorubicin-induced cardiomyopathy.
Myers, C. (1998) · PubMed · Cited by 168
The Power and Potential of Doxorubicin‐DNA Adducts
Cutts, S. M., Nudelman, A., Rephaeli, A., & Phillips, D. R. (2005) · IUBMB Life · doi:10.1080/15216540500079093 · Cited by 168
Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1
Denard, B., Lee, C., & Ye, J. (2012) · eLife · doi:10.7554/elife.00090 · Cited by 162
Ji, C., Yang, B., Yang, Y.-L., He, S.-H., Miao, D.-S., He, L., & Bi, Z.-G. (2010) · Oncogene · doi:10.1038/onc.2010.379 · Cited by 161
A role for ceramide in driving cancer cell resistance to doxorubicin
Liu, Y., Yu, J. Y., Yin, D., Patwardhan, G. A., Gupta, V. K., Hirabayashi, Y., Holleran, W. M., Giuliano, A. E., Jazwinski, S. M., Gouazé‐Andersson, V., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-092981 · Cited by 161
Structural plasticity of single chromatin fibers revealed by torsional manipulation
Bancaud, A., Conde e Silva, N., Barbi, M., Wagner, G., Allemand, J.-F., Mozziconacci, J., Lavelle, C., Croquette, V., Victor, J.-M., Prunell, A., et al. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1087 · Cited by 161
Kato, S., Burke, P., Koch, T. H., & Bierbaum, V. M. (2001) · Analytical Chemistry · doi:10.1021/ac001498q · Cited by 157
Voreloxin Is an Anticancer Quinolone Derivative that Intercalates DNA and Poisons Topoisomerase II
Hawtin, R. E., Stockett, D. E., Byl, J. A. W., McDowell, R. S., Tan, N., Arkin, M. R., Conroy, A., Yang, W., Osheroff, N., & Fox, J. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010186 · Cited by 148
Carpenter, A. J., & Porter, A. C. G. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-08-0732 · Cited by 139
Lee, M. S., & Garrard, W. T. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07988.x · Cited by 137
Nucleosome Chiral Transition under Positive Torsional Stress in Single Chromatin Fibers
Bancaud, A., Wagner, G., Silva, N. C. E., Lavelle, C., Wong, H., Mozziconacci, J., Barbi, M., Sivolob, A., Cam, É. L., Mouawad, L., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.037 · Cited by 137
Formation of nucleosomes on positively supercoiled DNA.
Clark, D. J., & Felsenfeld, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07960.x · Cited by 132
Taatjes, D. J., Gaudiano, G., Resing, K. A., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960835d · Cited by 131
Mode of action of topoisomerase II-targeting agents at a specific DNA sequence
Sørensen, B. S., Sinding, J., Andersen, A. H., Alsner, J., Jensen, P. B., & Westergaard, O. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90863-f · Cited by 122
Doxorubicin Enhances Nucleosome Turnover around Promoters
Yang, F., Kemp, C. J., & Henikoff, S. (2013) · Current Biology · doi:10.1016/j.cub.2013.03.043 · Cited by 122
Self-citationCatalano, M. G., Fortunati, N., Pugliese, M., Poli, R., Bosco, O., Mastrocola, R., Aragno, M., & Boccuzzi, G. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06970 · Cited by 121
Positive supercoiling of DNA greatly diminishes mRNA synthesis in yeast.
Gartenberg, M. R., & Wang, J. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11461 · Cited by 110
Delpy, E. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00142-x · Cited by 94
Coldwell, K. E., Cutts, S. M., Ognibene, T. J., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn439 · Cited by 87
Topoisomerase II is required for the production of long Pol II gene transcripts in yeast
Joshi, R. S., Piña, B., & Roca, J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks626 · Cited by 87
Jirkovská, A., Jansová, H., Macková, E., Macháček, M., Hašková, P., Tichotová, L., Štěrba, M., & Šimůnek, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076676 · Cited by 86
Suppression of Glucosylceramide Synthase Restores p53-Dependent Apoptosis in Mutant p53 Cancer Cells
Liu, Y., Patwardhan, G. A., Bhinge, K. N., Gupta, V. K., Gu, X., & Jazwinski, S. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3107 · Cited by 86
Alkylation of DNA by the Anthracycline, Antitumor Drugs Adriamycin and Daunomycin
Taatjes, D. J., Gaudiano, G., Resing, K. A., & Koch, T. H. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960519z · Cited by 84
Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation
Forrest, R. A., Swift, L. P., Rephaeli, A., Nudelman, A., Kimura, K., Phillips, D. R., & Cutts, S. M. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.02.026 · Cited by 83
In vivo synergy between topoisomerase II and histone deacetylase inhibitors: predictive correlates
Marchion, D. C., Biçaku, E., DAUD, A. I., Sullivan, D. M., & Münster, P. N. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0194 · Cited by 74
Uchida, Y., Itoh, M., Taguchi, Y., Yamaoka, S., Umehara, H., Ichikawa, S., Hirabayashi, Y., Holleran, W. M., & Okazaki, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1476 · Cited by 73
Thomä, N. H., Czyzewski, B. K., Alexeev, A., et al. (2005) · Cited by 69
Magnetic tweezers measurements of the nanomechanical properties of DNA in the presence of drugs
Salerno, D., Brogioli, D., Cassina, V., Turchi, D. M., Beretta, G. L., Seruggia, D., Ziano, R., Zunino, F., & Mantegazza, F. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq597 · Cited by 68
Gajewski, E., Gaur, S., Akman, S. A., Matsumoto, L., van Balgooy, J. N. A., & Doroshow, J. H. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.03.022 · Cited by 54
Doroshow, J. H., Synold, T. W., Somlo, G., Akman, S. A., & Gajewski, E. (2001) · Blood · doi:10.1182/blood.v97.9.2839 · Cited by 52
Niacin Status Impacts Chromatin Structure 1–3
Kirkland, J. B. (2009) · Journal of Nutrition · doi:10.3945/jn.109.111757 · Cited by 48
Strigun, A., Wahrheit, J., Niklas, J., Heinzle, E., & Noor, F. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr298 · Cited by 46
Kawase, M., Watanabe, M., Kondo, T., Yabu, T., Taguchi, Y., Umehara, H., Uchiyama, T., Mizuno, K., & Okazaki, T. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00301-3 · Cited by 41
Engel, D., Nudelman, A., Levovich, I., Gruss-Fischer, T., Entin‐Meer, M., Phillips, D. R., Cutts, S. M., & Rephaeli, A. (2006) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-006-0116-6 · Cited by 27
Chen, Q., Denard, B. S., Huang, H., & Ye, J. (2012) · Journal of Virology · doi:10.1128/jvi.01984-12 · Cited by 16
Cited by
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Cardinale, D., Colombo, A., Bacchiani, G., Tedeschi, I., Meroni, C. A., Veglia, F., Civelli, M., Lamantia, G., Colombo, N., Curigliano, G., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013777 · Cited by 1,733
Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
Kciuk, M., Gielecińska, A., Mujwar, S., Kołat, D., Kałuzińska-Kołat, Ż., Celik, I., & Kontek, R. (2023) · Cells · doi:10.3390/cells12040659 · Cited by 810
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come
Yingchoncharoen, P., Kalinowski, D. S., & Richardson, D. R. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012070 · Cited by 744
Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer
Abu Samaan, T. M., Samec, M., Liskova, A., Kubatka, P., & Büsselberg, D. (2019) · Biomolecules · doi:10.3390/biom9120789 · Cited by 569
Thermoresponsive polymer nanocarriers for biomedical applications
Bordat, A., Boissenot, T., Nicolas, J., & Tsapis, N. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.005 · Cited by 415
Metadata
- Authors
- Yang, F., Teves, S. S., Kemp, C. J., & Henikoff, S.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 1845
- Issue
- 1
- Pages
- 84-89
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W2049573968
- Cited by
- 695
- References
- 68
- FWCI
- 9.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.